Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.17 $1.66 Friday, 10th May 2024 IFRX stock ended at $1.18. This is 1.67% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 6.41% from a day low at $1.17 to a day high of $1.25.
90 days $1.17 $1.92
52 weeks $1.14 $5.20

Historical InflaRx N.V. prices

Date Open High Low Close Volume
Jun 20, 2023 $4.65 $4.65 $4.39 $4.50 279 530
Jun 16, 2023 $4.45 $4.67 $4.36 $4.65 253 089
Jun 15, 2023 $4.46 $4.61 $4.28 $4.45 242 636
Jun 14, 2023 $4.66 $4.66 $4.39 $4.50 238 276
Jun 13, 2023 $4.45 $4.57 $4.31 $4.57 205 721
Jun 12, 2023 $4.11 $4.47 $4.06 $4.46 339 085
Jun 09, 2023 $4.04 $4.18 $4.02 $4.16 174 961
Jun 08, 2023 $4.12 $4.14 $4.00 $4.01 285 933
Jun 07, 2023 $4.16 $4.30 $4.09 $4.12 371 422
Jun 06, 2023 $4.17 $4.22 $4.07 $4.21 170 736
Jun 05, 2023 $4.22 $4.26 $4.11 $4.15 183 186
Jun 02, 2023 $4.30 $4.35 $4.09 $4.21 283 177
Jun 01, 2023 $4.17 $4.34 $4.17 $4.31 333 067
May 31, 2023 $4.10 $4.25 $4.06 $4.19 249 581
May 30, 2023 $4.17 $4.21 $4.10 $4.15 164 519
May 26, 2023 $4.16 $4.20 $4.03 $4.16 415 424
May 25, 2023 $4.24 $4.25 $4.09 $4.10 223 319
May 24, 2023 $4.22 $4.28 $4.14 $4.21 290 565
May 23, 2023 $4.54 $4.54 $4.26 $4.34 307 822
May 22, 2023 $4.58 $4.63 $4.37 $4.53 461 497
May 19, 2023 $4.39 $4.57 $4.39 $4.57 212 329
May 18, 2023 $4.75 $4.78 $4.36 $4.37 399 034
May 17, 2023 $4.90 $4.92 $4.75 $4.75 155 937
May 16, 2023 $4.97 $5.05 $4.58 $4.89 391 284
May 15, 2023 $5.15 $5.20 $4.83 $4.84 290 773
Click to get the best stock tips daily for free!

About InflaRx N.V.

InflaRx N.V. InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III c... IFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT